Unraveling the complex love-hate relationship between estrogen and breast cancer. Learn how this vital hormone can both drive and help treat the most common type of breast cancer.
Explore how genetic polymorphisms affect breast cancer risk in women using estrogen-plus-progestin hormone therapy and the future of personalized medicine.
Exploring CB-839, a glutaminase inhibitor showing promise in treating basal breast cancer by targeting cancer cell metabolism.
Discover how EGCG from green tea disrupts breast cancer cell metabolism by targeting glucose utilization and the Warburg Effect.
Discover how genetic variations in CYP2D6, CYP3A5, SULT1A1 and UGT2B15 enzymes determine tamoxifen effectiveness in breast cancer treatment through pharmacogenetics.
Explore MPZL3 as a pan-cancer biomarker with focus on breast cancer - its biological functions, prognostic value, research tools and future clinical applications.